Literature DB >> 14709505

Nasal/buccal midazolam use in the community.

M T Wilson1, S Macleod, M E O'Regan.   

Abstract

A telephone survey was carried out to evaluate the effectiveness and convenience of nasal/buccal midazolam in terminating prolonged seizures in the community. A total of 33/40 (83%) families who had used it found it effective and easy to use; 20/24 (83%) preferred using midazolam to rectal diazepam.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14709505      PMCID: PMC1755919          DOI: 10.1136/adc.2002.019836

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Buccal midazolam: is a test dose in hospital needed?

Authors:  D Hindley; H Jameson
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

2.  Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.

Authors:  Lenneke Schrier; Rob Zuiker; Frans W H M Merkus; Erica S Klaassen; Zheng Guan; Bert Tuk; Joop M A van Gerven; Ronald van der Geest; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2016-12-20       Impact factor: 4.335

3.  Significant hypotension following buccal midazolam administration.

Authors:  Maria Kensche; Josemir W Sander; Sanjay M Sisodiya
Journal:  BMJ Case Rep       Date:  2010-12-15

Review 4.  A Common Reference-Based Indirect Comparison Meta-Analysis of Buccal versus Intranasal Midazolam for Early Status Epilepticus.

Authors:  Francesco Brigo; Raffaele Nardone; Frediano Tezzon; Eugen Trinka
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

5.  Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage.

Authors:  Shyamoshree Basu; Amal Kumar Bandyopadhyay
Journal:  AAPS PharmSciTech       Date:  2010-08-04       Impact factor: 3.246

Review 6.  Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures.

Authors:  Karly P Garnock-Jones
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

Review 7.  Recent advances in febrile seizures.

Authors:  Rekha Mittal
Journal:  Indian J Pediatr       Date:  2014-08-08       Impact factor: 1.967

Review 8.  Intranasal delivery of antiepileptic medications for treatment of seizures.

Authors:  Daniel P Wermeling
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

9.  The cost effectiveness of licensed oromucosal midazolam (Buccolam(®)) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited.

Authors:  Dawn Lee; Daniel Gladwell; Anthony J Batty; Nic Brereton; Elaine Tate
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

10.  Intranasal midazolam compared with intravenous diazepam in patients suffering from acute seizure: a randomized clinical trial.

Authors:  Mohsen Javadzadeh; Kourosh Sheibani; Mozhgan Hashemieh; Hedyeh Saneifard
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.